Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2008-8-26
pubmed:abstractText
In SPARCL, treatment with atorvastatin 80 mg daily reduced stroke risk in patients with recent stroke or TIA and no known coronary heart disease by 16% versus placebo over 4.9 years of follow-up. The purpose of this secondary analysis was to determine whether men and women similarly benefited from randomization to statin treatment.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1524-4628
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2444-8
pubmed:dateRevised
2008-11-12
pubmed:meshHeading
pubmed-meshheading:18617654-Apolipoprotein A-I, pubmed-meshheading:18617654-Blood Pressure, pubmed-meshheading:18617654-Cholesterol, pubmed-meshheading:18617654-Data Interpretation, Statistical, pubmed-meshheading:18617654-Female, pubmed-meshheading:18617654-Heptanoic Acids, pubmed-meshheading:18617654-Humans, pubmed-meshheading:18617654-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:18617654-Hypertension, pubmed-meshheading:18617654-Logistic Models, pubmed-meshheading:18617654-Male, pubmed-meshheading:18617654-Middle Aged, pubmed-meshheading:18617654-Pyrroles, pubmed-meshheading:18617654-Reproducibility of Results, pubmed-meshheading:18617654-Sex Characteristics, pubmed-meshheading:18617654-Sex Factors, pubmed-meshheading:18617654-Stroke, pubmed-meshheading:18617654-Treatment Outcome, pubmed-meshheading:18617654-Triglycerides
pubmed:year
2008
pubmed:articleTitle
Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study.
pubmed:affiliation
Duke University Medical Center, Durham, NC 27710, USA. golds004@mc.duke.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't